# FDA recall D-1672-2012

> **Hospira Inc.** · Class II · drug recall initiated 2012-08-03.

## Product

Propofol Injectable Emulsion, 1%, 1 g/100 mL (10 mg/mL), 100 ml Single patient infusion vial, Rx only, Hospira, Inc. Lake Forest, IL 60045 USA, NDC 0409-4699-24

## Reason for recall

Presence of Particulate Matter: A single visible particulate was observed and confirmed in a sample bottle during retain inspection.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1672-2012
- **Recalling firm:** Hospira Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-08-03
- **Report date:** 2012-09-05
- **Termination date:** 2014-05-06

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1672-2012

## Citation

> AI Analytics. FDA recall D-1672-2012. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-1672-2012. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*